1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(5-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea

ID: ALA4435851

Chembl Id: CHEMBL4435851

PubChem CID: 139600306

Max Phase: Preclinical

Molecular Formula: C24H21ClF3N5O

Molecular Weight: 487.91

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2cccc3[nH]c4c(c23)CC(NC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)CC4)cn1

Standard InChI:  InChI=1S/C24H21ClF3N5O/c1-33-12-13(11-29-33)16-3-2-4-21-22(16)17-9-14(6-8-20(17)32-21)30-23(34)31-15-5-7-19(25)18(10-15)24(26,27)28/h2-5,7,10-12,14,32H,6,8-9H2,1H3,(H2,30,31,34)

Standard InChI Key:  RTILPKXOEYEQSE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4435851

    ---

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lewis lung carcinoma cell line (1243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.91Molecular Weight (Monoisotopic): 487.1387AlogP: 5.92#Rotatable Bonds: 3
Polar Surface Area: 74.74Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.32CX Basic pKa: 1.81CX LogP: 5.08CX LogD: 5.08
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -1.79

References

1. Pei H, Qin J, Wang F, Tan B, Zhao Z, Peng Y, Yu F, Li E, Liu M, Zhang R, Liu B, Du B, Chen Y..  (2019)  Discovery of potent ureido tetrahydrocarbazole derivatives for cancer treatments through targeting tumor-associated macrophages.,  183  [PMID:31605873] [10.1016/j.ejmech.2019.111741]

Source